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cultured in chondrogenic media without TGF-b3 (ICM) for 24 h. Human
MSCs obtained from healthy donors were labelled with Cell Tracker Red
and DAPI, and added to explants at a cell density of 1−4×106 cells/ml for
20–120min at 37ºC with agitation. Unattached cells were removed and
explants were either processed immediately or treated with chondrogenic
media containing TGF-b3 (CCM) or ICM for 14 days. Proteoglycan (GAG)
levels were measured by Alcian Blue and PicoGreen assays and GAG
synthesis determined using S35 incorporation. Cartilage disks incubated
without cells were used as controls. Explants were pre-treated with 0.25%
trypsin/EDTA and collagenase (1mg/ml), 0.25% trypsin/EDTA alone,
collagenase alone and PBS alone. Formalin-ﬁxed, parafﬁn-embedded
sections were stained with Toluidine blue or processed for ﬂuorescence
microscopy. Bound cells were quantiﬁed using a systematically random-
ized stereological method that enabled unbiased estimation of numerical
density.
Results: Osteoarthritic goat cartilage explants were used to establish the
explant culture system. Mean accumulated GAG/DNA and proteoglycan
release was consistent in explants cultured in serum-containing media,
CCM and ICM over 14 days. Sulphate incorporation was also similar
in serum-containing media and CCM but signiﬁcantly lower in explants
cultured in ICM over 14 days. Maximum binding of MSCs to OA car-
tilage was observed in a free ﬂoating system with cartilage from the
tibial plateau. At lower attachment times (20min), a density-dependent
increase in binding was observed and the level of cell adherence was
determined using stereological assessment. Explant exposure to trypsin
resulted in increased MSC binding while treatment with collagenase had
no effect. Bound cells survived and started to differentiate to promote
surface repair of the cartilage when exposed to CCM for 14 days.
Conclusions: This system of explant culture and cell attachment allows
evaluation of the ability of targeted cells to repair the cartilage surface.
MSC binding to OA cartilage was dependent on numerous factors includ-
ing culture conditions, cell number and exposure time. Adherent MSCs
underwent a morphological change and elaborated a cartilaginous matrix.
Strategies for stem cell-mediated repair of ﬁbrillated cartilage may require
targeting of stem cells to damaged cartilage in early OA.
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Purpose: The aim of this study was to test the hypothesis that senes-
cence contributes to a decreased capacity of mesenchymal stem cells
(MSCs) to self-renew in osteoarthritis (OA) for normal tissue homeostasis
and to study the mechanisms by which this may occur. To this end, we
examined factors which contribute to cellular senescence, such as the
expression of cell cycle inhibitors (p16, p21 and p27) and the telomerase
catalytic component (hTERT), telomerase activity and telomere length.
Methods: MSCs were isolated from the bone marrow of OA patients
undergoing hip and knee replacement surgery and normal unaffected
donors. All procedures were performed with informed consent and ap-
proved by the Clinical Research Ethical Committee at University College
Hospital, Galway. Isolated MSCs were subjected to osteogenic, chondro-
genic and adipogenic assays and doubling times for OA and control MSCs
recorded. Genomic DNA and RNA was isolated from the MSCs and
used to determine telomere length by the telomere length assay (Roche)
and expression of cell cycle inhibitors and hTERT using real-time PCR,
respectively. Protein was also extracted for assessment of telomerase
activity using the ELISA-based TRAP assay and determination of cell
cycle inhibitor levels by Western blotting.
Results: OA and control MSCs differentiated along the adipo-, osteo-
and chondrogenic pathways under appropriate stimulation. Population
doublings of OA (6.4±2.5 days) and control MSCs (3.85±.212 days)
were measured. Protein (10mg) was extracted from MSC samples and
subjected to the PCR-based TRAP assay to measure telomerase activity.
Both OA and control MSCs were negative for telomerase relative to
identical amount of protein extracted from the Jurkat T cell line, although
trends point to higher telomerase activity in the control compared to OA.
Genomic DNA was isolated from both groups and analysed for telom-
ere length using the TeloTAGGG Telomere Length Assay, with results
suggesting no difference in telomere length between MSCs from control
and OA MSCs. Total RNA was extracted from both groups, converted
to cDNA and analysed for relative p16, p21, p27 and hTERT gene
expression using SYBR green real-time quantitative PCR chemistry and
the 2-DDCT method. p16 gene expression was slightly reduced in OA
relative to control samples while p21 expression was increased 2-fold. p27
expression was unchanged and hTERT was not detected in OA MSCs or
controls. Increased protein levels of p21 in OA MSCs were detected by
Western blotting.
Conclusions: The data does not suggest an association of telomerase-
related cellular senescence and the slower growth kinetics seen in MSCs
isolated from osteoarthritic patients, due to the low telomerase activity,
lack of hTERT expression and identical telomere length in OA and control
MSCs. However, the increased p21 expression along with slightly reduced
p16 levels in OA relative to controls is interesting and warrants further
investigation. p16 acts through the cyclin dependent kinases to maintain
normal cells in G1 growth arrest while p21 is upregulated by p53 and
plays an important role in inducing cell cycle arrest. The increased p21
expression observed in this study may indicate increased senescence of
stem cells in OA.
502 CHONDROGENESIS FROM ADIPOSE TISSUE-DERIVED
MESENCHYMAL STEM CELLS
G-I. Im, H-J. Kim. Dongguk University Int’l Hospital, Goyang, REPUBLIC
OF KOREA
Purpose: While pioneering studies demonstrated the chondrogenic po-
tential of adipose-tissue derived mesenchymal stem cells (ATMSCs),
some subsequent examinations have reported that ATMSCs have an infe-
rior chondrogenic potential to that of bone marrow derived mesenchymal
stem cells (BMMSCs).
This study examined the combination of growth factors that would induce
effective chondrogenesis from ATMSCs that is comparable to BMMSCs.
Methods: Human mesenchymal stem cells were isolated from bone
marrow (BMMSCs), and adipose tissue (ATMSCs). These cells were
characterized by ﬂow cytometry analysis for CD34, CD45, CD73, and
CD166. Chondrogenesis was induced by culturing the ATMSCs in pellets
with the following growth factors: #1 without growth factors (negative
control): #2, 5 ng/ml of TGF-b2; #3, 100 ng/ml of BMP-2; #4, 100 ng/ml of
BMP-6; #5, 100 ng/ml of BMP-7; #6, 5 ng/ml of TGF-b2 and 100 ng/ml of
BMP-2; #7, 5 ng/ml of TGF-b2 and 100 ng/ml of BMP-6; and #8, 5 ng/ml
of TGF-b2 and 100 ng/ml of BMP-7. BMMSCs cultured under the same
condition as in #2 were used as the negative and positive controls. After
4 weeks in-vitro culture, the pellets were harvested for DNA quantiﬁcation,
analysis of the glycosaminoglycan contents, reverse transcription and
real-time PCR for collagen type I (Col1A1), collagen type II (Col2A1),
collagen type X (Col10A1), sox-9. Safranin-O and immunohistochemical
staining for type II collagen as well as histological analysis were carried
out, and semiquantitative scoring was performed based on the histological
ﬁndings.
Results: After 4 weeks of in-vitro culture, GAG assay, real-time RT-PCR
and histological ﬁndings demonstrated that culturing the ATMSCs using a
combination of 5 ng/ml of TGF-b2 and 100 ng/ml of BMP-7 most effectively
induced chondrogenesis.
Conclusions: The overall results suggest that appropriate combinations
of growth factors can overcome the intrinsic inferior chondrogenic poten-
tials of ATMSCs to some degree.
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Purpose: The use of chondrocytes graft in a gel allows to simplify the
surgical technique with no leakage risk and to propose an implant of
differentiated chondrocytes distributed homogeneously throughout the
condyle lesion.
Methods: A phase II prospective study of this graft in a unique os-
teochondral lesion of the femoral condyle reaching less than 5 cm2
surface, grade 3 and 4 (ICRS) invalidating (subjective IKDC Score <55),
of traumatic origin or osteochondritis dissecans has been conducted by
4 French centers from August 2002 to August 2006, with a follow up of
24 months. The mean criterion was the evolution of the subjective IKDC
score (If 13 patients presented an evolution of 10 points, the treatment
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was considered as efﬁcient (a=10% b=10%)), the secondary criteria
were: the results at 24 months for arthroscopy, histology, MRI, and the
evaluation of the surgical technique.
Treatment: Biopsy of 200 to 300mg of cartilage from a non bearing
zone of the knee, cellular expansion and incubation in an agarose
and alginate hydrogel with manufacturing of 10, 14 or 18mm diameter
implants distributed in the lesion.
Results: 20 patients have been included, 17 have been implanted, (a
chondrocalcinosis, a culture failure, a ﬁbrocartilage reconstruction have
not been implanted). Patients characteristics: Average age: 30 years old,
12 Men/5 Women, 10 OD, Average IKDC initial score: 37, Average lesions’
surface 3 cm2. Mean criterion: IKDC at 24 months: 77.8 (p 3 cm2, and
almost signiﬁcant for OD and grade 4 lesions. MRI: 10 patients on 15 pre-
sented an identical signal/normal cartilage, for 11 patients/15 no visible
transition. Arthroscopies: 13 realized with an average ICRS score of 10 on
12. Histology: O’Driscoll Average score on 21: 16. 8 patients presented
a mostly hyaline cartilage, 3 a mixed hyaline and 1 ﬁbrocartilage. The
average surgery time was 41 minutes.
Conclusions: The cartilage graft in a CARTIPATCH® hydrogel conﬁrms
a signiﬁcant clinical improvement especially for deep and large lesions.
The use of a matrix allowing a homogeneous distribution and no cellular
leakage can explain the good histological results with over 60% of the
repaired cartilage mostly hyaline at 24 months. Two phase III studies one
versus osteochondral autografts and one versus microfracture have been
started.
Therapy – Non-Pharmacologic
505 EFFECTS OF JOINT LAVAGE IN PATIENTS WITH
OSTEOARTHRITIS OF THE KNEE: META-ANALYSIS OF
RANDOMIZED CONTROLLED TRIALS
J. Avouac, T. Bardin, P. Richette. Hoˆpital Lariboisie`re, Paris, FRANCE
Purpose: To assess the clinical relevance of joint lavage alone or com-
bined with intraarticular steroid injection to improve pain and function in
osteoarthritis (OA) of the knee.
Methods: A systematic literature search was performed in electronic
databases (Medline, Embase and Cochrane database) up to April 2008.
References of the papers were hand searched to identify additional rele-
vant reports. There was no language restriction. All randomized controlled
trials (RCTs) performed on patients with knee OA with parallel groups
and evaluating either (1) the efﬁcacy of joint lavage alone versus placebo
or (2) joint lavage combined with steroid injection versus joint lavage
alone, were selected. Efﬁcacy was evaluated on pain intensity (pain
visual analogic scale [VAS], Western Ontario and Mac master universities
Osteoarthritis index [WOMAC] subscale for pain or pain on movement
VAS) and physical function (WOMAC function or Lequesne’s functional
index). The time point for evaluation was a priori decided and ﬁxed at three
months. Effect sizes were calculated using RevMan to compare results
across studies. We used the standardized mean difference (change from
baseline pain or function at 3 months) as our measure of effect size for
each study.
Results: From the 334 articles identiﬁed, seven RCTs (four studies
analyzed joint lavage versus placebo, and three joint lavage with steroid
injection versus joint lavage alone) were included and analyzed, i.e. a total
of 1009 patients (582 in the active group and 427 in the control group).
The median (min-max) value of the journals’ impact factor in which were
published the different trials was 5.78 (3.06−51.3) and the mean (SD)
Jadad score was 3.5 (1.5). The pooled effect sizes of joint lavage versus
placebo were not signiﬁcant for pain intensity (ES=−0.02 [−0.21, 0.17])
(ﬁgure 1) and physical function (ES=−0.16 [−0.35, 0.03]). The pooled
effect sizes of joint lavage combined with steroid injection versus joint
lavage alone were also not signiﬁcant for pain intensity (−1.24 [−1.49,
−0.99]) or physical function (ES=0.09 [−0.28, 0.45]).
Conclusions: This meta-analysis suggests that at three months (i) joint
lavage alone does not provide signiﬁcant improvement in pain or function
over placebo, (ii) combination of lavage and intraarticular steroid injection
is no more efﬁcacious than lavage alone.
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Purpose: Patients may alternate between different hyaluronic acid prod-
ucts and experience different degrees of efﬁcacy. This may be the result
of differing molecular weight needs within the synovial ﬂuid of patients
through the course of their osteoarthritis symptoms.
Methods: To compare the efﬁcacy and safety of different molecular
weight hyaluronic acid alone or in combination in patients with osteoarthri-
tis of the knee we conducted a randomized, prospective, double blind
cohort followed for 16 weeks in which patients were randomized at
baseline to receive a three intra-articular injection series with one of:
DMW (Dual molecular weight) (580–780 kDa + 1.2 to 2.0 million); LMW
(Low molecular weight) (500–730 kDa); HMW (High molecular weight)
(6 million); or saline placebo over 3 weeks. Patients completed baseline
assessment of rest and walking VAS pain (primary efﬁcacy variable),
collection of a 5-point categorical global satisfaction score and record of
adverse events.
Results: Two-hundred and twenty-ﬁve patients (age 68±8 y) were
screened and two hundred were randomized to one of the four groups.
There were no differences at baseline between groups. At 4, 12 and
16 weeks respectively, walking VAS pain was signiﬁcantly improved
in all treatment groups vs Placebo: DMW (79.6%, p< 0.001; 85.6,
p< 0.001; 89.3%, p< 0.001); LMW (73.6%, p< 0.001; 76.4, p< 0.001;
81.3%, p< 0.001) and HMW (69.1%, p< 0.001; 81.0, p< 0.001; 79.1%,
p< 0.001). Patients in the DMW group had signiﬁcantly greater improve-
ment (p< 0.007) in VAS walking pain by three weeks (following the
second injection) compared to all groups. This difference was persistent
to 16 weeks.
Conclusions: Greater improvement in patients who received the DMW
product was achieved by the second injection persistent at 16 weeks. This
suggests that patients who receive a combination of molecular weight
hyaluronic acid may have superior results.
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ON THE CLINICAL SYMPTOMS
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Purpose: International recommendations (EULAR) about managing knee
osteoarthritis support the concomitant use of medications and non-
pharmacological treatments. The aim of this clinical survey was to de-
termine practice patterns among general practitioners (GPs) in France
regarding non-pharmacological treatments in patients with recurrent or
persistent pain from knee osteoarthritis.
Methods: Survey among GPs. No support was received from pharma-
ceutical companies. Each GP completed a questionnaire about the ﬁrst
patient seen for recent pain exacerbation due to known knee osteoarthri-
tis. The questionnaire collected the main clinical symptoms, in order
to distinguish mechanical pain from an inﬂammatory osteoarthritis ﬂare
(nocturnal pain and synovial ﬂuid effusion), and the non-pharmacological
treatments prescribed at the end of the visit based on the clinical mani-
festations.
Results: 638 questionnaires were completed; women contributed 70% of
the patients, mean age was 66 years and mean BMI was 28 kg/m2; both
knees were affected in 50% of patients. A limp was the most common
symptom (82%); mechanical pain was noted in 75% and joint effusion in
37% of patients. Nocturnal pain with a joint effusion was present in 12%
of patients.
Overall, 30.9% of GPs recommended rest and 36.5% reducing walking.
Rest was recommended by 50% of GPs for patients with nocturnal
pain and joint effusion (ﬂare) compared to 20% for patients with neither
symptom. Although EULAR guidelines recommend regular exercise in
the absence of ﬂares, only 34.5% of GPs prescribed physical therapy.
Surprisingly, physical therapy was prescribed more often in patients with
ﬂares (46%) than without ﬂares (33.4%). Most GPs (66.6%) recom-
mended a weight-reduction diet. Using a cane was recommended by
